Blog

Cobra Biologics embarks on £15 million gene therapy manufacturing expansion – The Pharma Letter (registration)

Cobra Biologics embarks on £15 million gene therapy manufacturing expansion
The Pharma Letter (registration)
Cobra Biologics, an international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals, is to expand operations at its sites in the UK and Sweden to meet the increased demand of gene and immunotherapy …

2017-04-19 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.